22 May 2013
Keywords: blow, orion, deramciclane, fails, phase, iii, anxiety
Article | 24 February 2003
Orion Pharma of Finland and partner Pharmacia have decided todiscontinue the development of deramciclane for generalized anxiety
disorder, owing to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 February 2003
© 2013 thepharmaletter.com